Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ENDOMETRIAL NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05797831
What this trial is testing

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Kartos Therapeutics, Inc. 268
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Testing effectiveness (Phase 2)Study completedNCT00542490
What this trial is testing

Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer

Who this might be right for
Endometrial CancerPapillary SerousClear Cell Endometrial Cancer
University of Oklahoma 23
Testing effectiveness (Phase 2)Ended earlyNCT03509207
What this trial is testing

Vorinostat (SAHA) in Uterine Sarcoma

Who this might be right for
LeiomyosarcomaEndometrial Stromal TumorsCarcinosarcomas Uterine
Medical University of Graz 3
Testing effectiveness (Phase 2)Looking for participantsNCT06760819
What this trial is testing

Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Solid TumorsHER2 Mutation
Bayer 111
Not applicableUnknownNCT04783467
What this trial is testing

Time Restricted Eating (TRE) Among Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
University of Utah 15
Testing effectiveness (Phase 2)UnknownNCT02188550
What this trial is testing

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

Who this might be right for
Ovarian CancerEndometrial Cancer
Sinai Hospital of Baltimore 20
Post-approval studies (Phase 4)Study completedNCT02872818
What this trial is testing

Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia

Who this might be right for
Apoptotic Signal Pathways in Endometrial Hyperplasia
Kayseri Education and Research Hospital 40
Testing effectiveness (Phase 2)Study completedNCT05156268
What this trial is testing

Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma

Who this might be right for
Endometrial Carcinosarcoma
Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT03367923
What this trial is testing

Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors

Who this might be right for
Cancer SurvivorEndometrial CarcinomaStage I Uterine Corpus Cancer AJCC v7+4 more
Stanford University 47
Not applicableLooking for participantsNCT07220239
What this trial is testing

Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome

Who this might be right for
Endometrial CancerLynch SyndromeScreening+1 more
Jessica D. St. Laurent, MD 25
Not applicableLooking for participantsNCT03787056
What this trial is testing

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Who this might be right for
CancerBreast CancerGastric Cancer+14 more
Hospices Civils de Lyon 410
Early research (Phase 1)Looking for participantsNCT07524322
What this trial is testing

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+6 more
Regor Pharmaceuticals Inc. 63
Post-approval studies (Phase 4)WithdrawnNCT01966575
What this trial is testing

Effect of Progestin-Induced Withdrawal Bleed on Ovulation Induction Cycles With Clomiphene Citrate

Who this might be right for
Polycystic Ovary SyndromeInfertility
University of British Columbia
Not applicableStudy completedNCT04122235
What this trial is testing

The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study

Who this might be right for
Gynecologic CancerGynecologic NeoplasmOvarian Cancer+3 more
Sorlandet Hospital HF 755
Not applicableUnknownNCT05669872
What this trial is testing

Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer

Who this might be right for
Gynecologic Cancer
Asan Medical Center 334
Not applicableStudy completedNCT01267357
What this trial is testing

P16 Staining as Prognostic Biomarker in Serous Papillary Endometrial Cancer

Who this might be right for
Serous Papillary Endometrial Cancer
Rambam Health Care Campus 62
Not applicableUnknownNCT03291275
What this trial is testing

Survival Outcomes of Uterine Malignancies in Chinese Population

Who this might be right for
Endometrial NeoplasmsSurvival
Lei Li 10,000
Testing effectiveness (Phase 2)Study completedNCT04212377
What this trial is testing

Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
Radboud University Medical Center 8
Testing effectiveness (Phase 2)Study completedNCT00610740
What this trial is testing

CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer
Masonic Cancer Center, University of Minnesota 18
Next Page